Veterinary Vaccines

Considerable progress has been made in the production of veterinary vaccines whether live or inactivated for animal use during the past two decades with the increasing use of continuous cell lines as a substrate and adoption of the fermentor technology for antigen production. These vaccines are produced for administration to domestic animals or wild species by parenteral or oral routes according to vaccine characteristics. More recently a third generation of live veterinary rabies vaccine has been developed using recombinant technology. Depending upon the expression system these vaccines are used either parentally or orally. Oral rabies vaccines are widely used in foxes in Europe and in racoons in the USA. Trials are under way for the oral immunization of dogs in developing countries.

  • Second-generation veterinary vaccines
  • Highly immunogenic inactivated cell culture vaccines
  • Third generation of live rabies vaccines
  • live or inactivated veterinary vaccines
  • Veterinary vaccines for parenteral use
  • Modified live-virus veterinary vaccines for oral immunization of wildlife
  • Recombinant veterinary vaccines for oral immunization of wildlife

Related Conference of Veterinary Vaccines

July 27-28, 2018

31st Annual Congress on Vaccines & Clinical Trials

Vancouver, Canada
October 22-23, 2018

30th World Congress on Vaccines and Immunization

Osaka, Japan

Veterinary Vaccines Conference Speakers

Recommended Sessions

Related Journals

Are you interested in